IO Biotech, Inc. — Director's Dealing 2021

Nov 5, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: IO Biotech, Inc. (IOBT)
CIK: 0001865494
Period of Report: 2021-11-04

Reporting Person: Vendola Keith A. (N/A)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants (Right to Buy)	$12.64		Common Stock (87065)		Direct
Warrants (Right to Buy)	$12.64		Common Stock (134324)		Direct

Footnotes

F1: These Warrants vest 25% on the one-year anniversary of the October 15, 2021 vesting commencement date, and then in 1/48 monthly increments thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause or by the reporting person within 24 months of a change of control.

F2: Warrants expire in annual increments on the fifth anniversary of the vesting date.